Bogler O, Raissi A, Colacci M, Beaman A, Biering-Sorensen T, Cressman A, Detsky A, Gosset A, Lassen MH, Kandel C, Khaykin Y, Barbosa D, Lapointe-Shaw L, MacFadden DR, Pearson A, Perkins BA, Rothman KJ, Skaarup KG, Weagle R, Yarnell C, Sholzberg M, Hodzic-Santor B, Lovblom E, Zipursky J, Quinn KL, Fralick M. Association between diabetes and mortality among adult patients hospitalized with COVID-19: a cohort study of hospitalized adults in Ontario, Canada, and Copenhagen, Denmark. Can J Diabetes. 2023 Jun;47(4):352-8. doi: 10.1016/j.jcjd.2023.02.005
Parikh R, Kurosky SK, Udall M, Chang J, Cappelleri JC, Doherty JP, Kaye JA. Treatment patterns and health outcomes in platinum-refractory or platinum-resistant ovarian cancer: a retrospective medical record review. Int J Gynecol Cancer. 2018 May;20(4):738-48. doi: 10.1097/IGC.0000000000001222
Herring WL, Herrmann JW. The single-day surgery scheduling problem: sequential decision-making and threshold-based heuristics. OR spectrum: quantitative approaches in management. 2012 Apr 1;34(2):429-59.
Alverez SA, Bae-Jump V, Havrilesky LJ, Calingaert B, Clarke-Pearson ADL, Soper JT, Gehrig PA. Attitudes regarding the use of hematopoietic colony-stimulating factor utilization and maintenance of relative dose intensity among gynecologic oncologists. Int J Gynecol Cancer. 2009 Apr;19(3):447-54.
Lancaster JM, Sayer RA, Blanchette C, Calingaert B, Konidari I, Gray J, Schildkraut J, Schomberg DW, Marks JR, Berchuck A. High expression of insulin-like growth factor binding protein–2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels. Int J Gynecol Cancer. 2006 Jul 1;16(4):1529-35.